# Double-blind, Randomised Study of A3384 in BAM/BAD

> **NCT02078856** · PHASE2 · COMPLETED · sponsor: **Albireo** · enrollment: 19 (actual)

## Conditions studied

- Bile Acid Malabsorption

## Interventions

- **DRUG:** A3384

## Key facts

- **NCT ID:** NCT02078856
- **Lead sponsor:** Albireo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078856, "Double-blind, Randomised Study of A3384 in BAM/BAD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02078856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*